These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease? Poliwoda H; Avenarius HJ Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823 [TBL] [Abstract][Full Text] [Related]
43. Role of platelet-active drugs in coronary artery disease. Sherry S Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025 [No Abstract] [Full Text] [Related]
44. [Platelet antiaggregants and arteriopathies]. Cristol R J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714 [No Abstract] [Full Text] [Related]
45. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684 [TBL] [Abstract][Full Text] [Related]
52. [Secondary prevention of ischemic heart disease. Evaluation of platelet function in patients treated with anticoagulants and cod liver oil]. Głab-Kordecka E Pol Arch Med Wewn; 1986 Jan; 75(1):3-12. PubMed ID: 3523447 [No Abstract] [Full Text] [Related]
53. Platelets and antiplatelet therapy in ischemic heart disease. Frishman WH; Miller KP Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576 [No Abstract] [Full Text] [Related]